Literature DB >> 27569222

Personalized lung cancer screening: the value of spirometry and emphysema as risk modifiers.

Firdaus A Mohamed Hoesein1, Pim A de Jong1.   

Abstract

Entities:  

Year:  2016        PMID： 27569222      PMCID： PMC4980372          DOI： 10.21037/atm.2016.05.59

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  11 in total

1.  Improving selection criteria for lung cancer screening. The potential role of emphysema.

Authors:  Pablo Sanchez-Salcedo; David O Wilson; Juan P de-Torres; Joel L Weissfeld; Juan Berto; Arantzazu Campo; Ana B Alcaide; Jesús Pueyo; Gorka Bastarrika; Luis M Seijo; Maria J Pajares; Ruben Pio; Luis M Montuenga; Javier J Zulueta
Journal:  Am J Respir Crit Care Med       Date:  2015-04-15       Impact factor: 21.405

2.  Optimizing lung cancer screening: nodule size, volume doubling time, morphology and evaluation of other diseases.

Authors:  Firdaus A A Mohamed Hoesein; Pim A de Jong; Onno M Mets
Journal:  Ann Transl Med       Date:  2015-02

Review 3.  Emphysema detected on computed tomography and risk of lung cancer: a systematic review and meta-analysis.

Authors:  Benjamin M Smith; Lancelot Pinto; Nicole Ezer; Nicola Sverzellati; Shigeo Muro; Kevin Schwartzman
Journal:  Lung Cancer       Date:  2012-03-20       Impact factor: 5.705

4.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

5.  Cost-effectiveness of CT screening in the National Lung Screening Trial.

Authors:  William C Black; Ilana F Gareen; Samir S Soneji; JoRean D Sicks; Emmett B Keeler; Denise R Aberle; Arash Naeim; Timothy R Church; Gerard A Silvestri; Jeremy Gorelick; Constantine Gatsonis
Journal:  N Engl J Med       Date:  2014-11-06       Impact factor: 91.245

6.  Targeting of low-dose CT screening according to the risk of lung-cancer death.

Authors:  Anil K Chaturvedi; Hormuzd A Katki; Stephanie A Kovalchik; Martin Tammemagi; Christine D Berg; Neil E Caporaso; Tom L Riley; Mary Korch; Gerard A Silvestri
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

7.  Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.

Authors:  Nanda Horeweg; Joost van Rosmalen; Marjolein A Heuvelmans; Carlijn M van der Aalst; Rozemarijn Vliegenthart; Ernst Th Scholten; Kevin ten Haaf; Kristiaan Nackaerts; Jan-Willem J Lammers; Carla Weenink; Harry J Groen; Peter van Ooijen; Pim A de Jong; Geertruida H de Bock; Willem Mali; Harry J de Koning; Matthijs Oudkerk
Journal:  Lancet Oncol       Date:  2014-10-01       Impact factor: 41.316

8.  Per cent emphysema is associated with respiratory and lung cancer mortality in the general population: a cohort study.

Authors:  Elizabeth C Oelsner; J Jeffrey Carr; Paul L Enright; Eric A Hoffman; Aaron R Folsom; Steven M Kawut; Richard A Kronmal; David J Lederer; Joao A C Lima; Gina S Lovasi; Benjamin M Smith; Steven J Shea; R Graham Barr
Journal:  Thorax       Date:  2016-04-05       Impact factor: 9.139

9.  Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.

Authors:  Harry J de Koning; Rafael Meza; Sylvia K Plevritis; Kevin ten Haaf; Vidit N Munshi; Jihyoun Jeon; Saadet Ayca Erdogan; Chung Yin Kong; Summer S Han; Joost van Rosmalen; Sung Eun Choi; Paul F Pinsky; Amy Berrington de Gonzalez; Christine D Berg; William C Black; Martin C Tammemägi; William D Hazelton; Eric J Feuer; Pamela M McMahon
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

10.  COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.

Authors:  R P Young; R J Hopkins; T Christmas; P N Black; P Metcalf; G D Gamble
Journal:  Eur Respir J       Date:  2009-02-05       Impact factor: 16.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.